Healthy individuals
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Male and female aged 20 and over 2) Subjects who follow the instructions by Principal/Clinical investigator or clinical staff at Clinical center, and can visit on a scheduled examination date 3) Subjects who agree to take the qualifying examination and OCT data acquisition 4) Subjects who sign an informed consent form to participate in the clinical study
Exclusion criteria
Exclusion criteria: 1) Exclusion criteria regarding systemic disease a) a) Diabetes mellitus b) b) Uncontrollable hypertension c) c) Cerebral infarction, cerebral hemorrhage, cranial nerve neoplasm and other central nervous system diseases affecting vision d) d) Cardiac, hepatic, renal and hematologic diseases, and other moderate to severe complications e) e) During systemic administration of steroid f) f) History of anticancer agent etc. g) g) Optically-stimulated epileptic seizure h) h) Dementia i) i) Other serious systemic diseases 2) Exclusion criteria regarding ocular disease a) a) History of keratorefractive surgery b) b) History of retinal photocoagulation c) c) History of intraocular surgery 3) Exclusion criteria regarding qualifying examination. 4) Exclusion criteria regarding OCT imaging Subjects who can or could have any difficulty associated with OCT data acquisition
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To demonstrate the three-dimensional distribution of macular thickness in normal subjects by spectral domain optical coherence tomography (SD-OCT), and to evaluate the association between macular thickness and sex, age, axial length, and race. | — |
Countries
Japan,Asia(except Japan),Europe